Freezing tumors to boost immune attack on stubborn melanoma
NCT ID NCT05779423
Summary
This study is testing if freezing one growing tumor (cryoablation) while giving two immunotherapy drugs (ipilimumab and nivolumab) can help control advanced melanoma that has continued to grow despite prior immunotherapy. It aims to see if this combination is safe and effective for about 37 adults with this condition. The approach is based on the idea that freezing a tumor may help the immune system better recognize and fight the cancer elsewhere in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital Cancer Center
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.